Company Overview and News

 
Hormel (HRL) to Report Q2 Earnings: What's in the Cards?

12h zacks
Hormel Foods Corporation (HRL - Free Report) is slated to report second-quarter fiscal 2018 (ended April 2018) results on May 24, before the market opens. The company recorded a negative average earnings surprise of 2.03%, over the past four quarters. However, in first-quarter fiscal 2018, its adjusted earnings of 44 cents per share came in line with the Zacks Consensus Estimate. Let’s see how things are shaping up prior to this announcement.

 
Constellation Brands Promotes Jim Sabia to Newly Created Role of Chief Marketing Officer

13h globenewswire
VICTOR, N.Y., May 22, 2018 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE:STZ) (NYSE:STZ.B), a leading beverage alcohol company, announced today that it has promoted Jim Sabia to the newly created role of Executive Vice President and Chief Marketing Officer, Constellation Brands. In this new role, Sabia will serve as the marketing lead for the company’s Beer and Wine & Spirits Divisions, responsible for all aspects of marketing across Constellation’s entire beverage alcohol portfolio.

1
Tracking Dan Loeb's Third Point Portfolio - Q1 2018 Update

2018-05-22 seekingalpha
Dan Loeb's 13F portfolio value decreased from $13.86B to $13.32B this quarter. The number of positions decreased from 44 to 40.

1
Is The Economy Overheating? - Cramer's Mad Money (5/17/18)

2018-05-18 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, May 17.

 
Aphria strikes deal with wine and spirits supplier Southern Glazer’s for cannabis distribution

2018-05-18 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

2
3 of the Best Penny Stocks To Buy Right Now

2018-05-16 investorplace
Penny stocks get a bad rap — and it’s somewhat well-deserved. While a price below $5 might make a stock seem “cheap,” that’s actually not the case. An investor’s ownership of a company on a percentage basis, and the valuation of that company, is what matters. Whether a stock is priced at $4, $0.40, or $400 doesn’t in and of itself affect the potential gains — or losses — in that stock. The best penny stocks to buy shouldn’t be buys because of their price — but rather their value.

 
Canopy applies to become first pot producer listed on NYSE

2018-05-14 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com

1
3 Emerging Industries, 3 Best Companies to Invest In Right Now

2018-05-11 investorplace
Investors wanting the best stocks to invest in right now often dream of finding the investment that was equivalent to buying Microsoft Corporation (NASDAQ:MSFT) in 1986 or Apple Inc. (NASDAQ:AAPL) in 1997 after Steve Jobs returned and began its turnaround. Such investments are difficult to find at those stages. When they become discovered, they do so as they are building an industry of the future.

1
Opko Health Shouldn't Be Down - Cramer's Lightning Round (5/9/18)

2018-05-10 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, May 9.

 
Replacing A High Yielder

2018-05-10 seekingalpha
I just sold my Gramercy Property Trust shares on the big M&A bump, not willing to put the M&A premium at risk.

 
Canada firm aims to tap into pot beverage market with cannabis beer

2018-05-06 lifestyle.inquirer.net
An upstart cannabis company has partnered with a Canadian university to produce — with government financial backing — what it says will be the world’s first beer made from the mind-altering drug.

 
Flash - Canada firm aims to tap into pot beverage market with cannabis beer - France 24

2018-05-05 france24
An upstart cannabis company has partnered with a Canadian university to produce -- with government financial backing -- what it says will be the world's first beer made from the mind-altering drug.

 
Canada firm aims to tap into pot beverage market with cannabis beer

2018-05-04 yahoo
Ottawa (AFP) - An upstart cannabis company has partnered with a Canadian university to produce -- with government financial backing -- what it says will be the world's first beer made from the mind-altering drug.

 
Why is CarMax (KMX) Up 1.3% Since Last Earnings Report?

2018-05-04 zacks
It has been about a month since the last earnings report for CarMax, Inc. (KMX - Free Report) . Shares have added about 1.3% in that time frame.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 21036P108